United Kingdom Rare Disease Drugs Research
11 comprehensive market analysis studies and research reports on the United Kingdom Rare Disease Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 136 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Monkeypox Vaccine and Treatment Market
CAGR: 10.1%
Study Period : 2021 - 2030
United States Ultomiris Drug Market
CAGR: 23.45%
Study Period : 2020 - 2031
Healthcare
Categories
11 Healthcare Reports
Categories
Showing 11 of 11 results in Rare Disease Drugs
Meniere's Disease Treatment Market
CAGR: 3.12%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Pfizer, GlaxoSmithKline, Teva Pharmaceutical Industries, Viatris, Sun Pharmaceuticals Industries
Starting at:$4,750
Neurotrophic Keratitis Treatment Market
CAGR: 5.58%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Dompé farmaceutici S.p.A., Bausch + Lomb, Laboratoires Théa, RegeneRx Biopharmaceuticals, Inc., AxoGen, Inc
Starting at:$4,750
Bullous Pemphigoid Market
CAGR: 9.80%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Abbvie, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Sanofi, UCB
Starting at:$4,750
TRENDING REPORTS
Monkeypox Vaccine and Treatment Market
CAGR: 10.1%
Study Period : 2021 - 2030
United States Ultomiris Drug Market
CAGR: 23.45%
Study Period : 2020 - 2031
Alpha Mannosidosis Market
CAGR: 16.40%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Chiesi Farmaceutici, Sobi, Orchard Therapeutics plc, Avrobio, Ultragenyx Pharmaceutical Inc.
Starting at:$4,750
Hypoparathyroidism Treatment Market
CAGR: 4%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Roche, Teva Pharmaceutical Industries, Amgen, Zhejiang NHU, EnteraBio Ltd.
Starting at:$4,750
Neuromyelitis Optica Spectrum Disorder Market
CAGR: 6.31%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Roche, TG Therapeutics, Opexa Therapeutics, Mitsubishi Tanabe Pharma, Horizon Therapeutics
Starting at:$4,750
Rare Disease Treatment Market
CAGR: 11.78%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Amgen, Biomarin Pharmaceutical, Bayer, Bristol-Myers Squibb, AstraZeneca
Starting at:$4,750
Rare Neurological Disease Treatment Market
CAGR: 6.66%
Study Period: 2022 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:CSL Behring, Merz Pharma, Kedrion Biopharma, US WorldMeds, Aquestive Therapeutics
Starting at:$4,750
Guillain-Barre Syndrome Market
CAGR: 5.7%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:CSL Behring, Takeda Pharmaceuticals, Grifols, Kedrion Biopharma, Octapharma
Starting at:$4,750
Scleroderma Therapeutics Market
CAGR: 7.68%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: United Kingdom
Major Players:Boehringer Ingelheim, Roche, Johnson & Johnson Services Inc. (Actelion), Bayer, Novartis
Starting at:$4,750
Orphan Drugs Market
CAGR: 6.36%
Study Period: 2020 - 2031
Starting at:$5,500
Country Covered: United Kingdom
Major Players:Novartis, Roche, Abbvie, Sanofi, Pfizer
Starting at:$5,500
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
